Miranda Weggeman

Chief Technology Officer
Fibriant B.V.

Presentation(s):

• PB0593 - Increased Percentage of Extended Aα Chain Fibrinogen (αE) in COVID-19 Patients

  Monday, July 11, 2022
  6:30 PM – 7:30 PM